Arkolith/Insider Trading/RCUS/Form 4

Jarrett Jennifer

Chief Operating OfficerArcus Biosciences, Inc. (RCUS) · full profile →Form 4 · filed Oct 8, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$751K
Net Open-Market Flow
-$751K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 8, 2025Option exercise(M)38K$1.23$46K252K
Oct 8, 2025Sell(S)38K$15.05$569K214K
Oct 6, 2025Sell(S)13K$14.54$182K214K
Oct 6, 2025Option exercise(M)13K$1.23$15K227K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 8, 2025Option exercise(M)38K—$0131K
Oct 6, 2025Option exercise(M)13K—$0169K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001671311-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML